Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
 

Emma Hall

Default user avatar

Institute of Cancer Research
15 Cotswold Road
Belmont
Sutton
SM2 5NG
United Kingdom

Email: emma.hall@icr.ac.uk
Web: Lab website

Other research projects by Emma Hall

CRUK/09/011: 111 Testis: A single arm multi-centre study evaluating a single cycle of BEP as adjuvant chemotherapy in high risk, stage 1 non-seminomatous germ cell tumours of the testis (NSGCTT).
Phase III Clinical Trial Grants
Funding period: 01 August 2009 to 31 July 2015

CRUK/07/004: BOXIT: A Randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder
Phase III Clinical Trial Grants
Funding period: 01 February 2007 to 31 January 2014

CRUK/06/016: CHHIP: a randomised phase III multicentre trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Phase III Clinical Trial Grants
Funding period: 01 August 2006 to 31 July 2016

CRUK/08/004: COSTAR: A Multicentre Randomised Study Of Cochlear Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy in Patients with Parotid Tumours
Phase III Clinical Trial Grants
Funding period: 01 September 2008 to 31 August 2016

CRUK/11/053: PROMPTS: A Prospective Randomised phase III study of Observation versus screening MRI and Pre-emptive Treatment in castrate resistant prostate cancer patients with Spinal metastasis.
Phase III Clinical Trial Grants
Funding period: 01 October 2012 to 31 March 2018

CRUK/11/027: POUT: Peri-Operative chemotherapy or sUrveillance in upper Tract urothelial cancer
Phase III Clinical Trial Grants
Funding period: 01 December 2011 to 30 November 2020

Phase III Clinical Trial Grants
Funding period: 01 September 2010 to 31 August 2017

Publications


Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)

Trials.2011;12 :78

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Lancet Oncol.2011;12 :127-136

More publications…